Aluoch JR. Management of sickle cell disease. A review. East Afr Med J 1991;68:576-81. A review of current treatment regimens in SCD.Search in Google Scholar
Burdick E. Sickle cell disease. Still a management challenge. Postgrad Med J 1994;96:107-10;113-5. Reviews the management of major complications in SCD.10.1080/00325481.1994.1194594029219720Search in Google Scholar
Campbell LC, Von Burton G, Holcombe RF. Transfusion therapy in sickle cell disease patients: methods and acute indications. J La State Med Soc 1993;145:515-21. Management of transfusion therapy of SCD patients with issues relating to alloimmunization and iron overload.Search in Google Scholar
Cummins D, Webb G, Shah N, Davies SC. Delayed haemolytic transfusion reactions in patients with sickle cell disease. Postgrad Med J 1991;67:689-91. Emphasis on the need for meticulous phenotyping and serologic assessment of sickle cell patients prior to transfusion therapy.10.1136/pgmj.67.789.68923990691924062Search in Google Scholar
Dabrow MB, Wilkins JC. Hematologic emergencies. Management of transfusion reactions and crisis in sickle cell disease. Postgrad Med J 1993;93:183-90. Review article of transfusion reactions and crisis in patients with SCD.10.1080/00325481.1993.117016688460076Search in Google Scholar
Hmida S, Mojaat N, Maamar M, Bejaoui M, Mediouni M, Boukef K. Red cell alloantibodies in patients with haemoglobinopathies. Nouv Rev Fr Haematol 1994;36:363-6. Alloimmunization to the Rh blood group was seen in 58.82% and to the Kell blood group in 26.47%; frequency of immunization was significantly lower in patients less than 5 years of age.Search in Google Scholar
Hundric-Haspl Z, Jurakovic-Loncar N, Grgicevic D, Balija M. Alloimmunizations following blood transfusions. Acta Med Croatia 1994;48:193-7.
A retrospective study to determine rate of alloimmunization against RBC antigens in hospitalized patients and the specificity of clinically significant alloantibodies. Incidence of alloantibodies was 5.1% (1–5 exposures), 87.9% (6–15 exposures), 6.8% (> 15 exposures).Search in Google Scholar
Issitt PD. Race-related red cell alloantibody problems. Br J Biomed Sci 1994;51:158-67.
Knowledge of an antibody-maker’s ethnic background can sometimes be used to accelerate identification of an antibody. The effects of differences in antigen frequency are considered in long-term transfusion support of some patients.Search in Google Scholar
Mallory D, Malamut D, Sandler SG. A decade of rare donor services in the United States. Report of the American Red Cross Rare Donor Registry. Vox Sang 1992;63:186-91. Patients with SCD require the largest amount of blood from the ARC Rare Donor Registry; strategies are discussed to meet future blood requirements.10.1159/000462259Search in Google Scholar
Michail-Merianou V. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58:50-5. Annotation not available.10.1111/j.1423-0410.1990.tb02055.x2316211Search in Google Scholar
